Skip to content
Delayed ~15 min

ACRS ACLARIS THERAPEUTICS

Health Care · Russell 2000

Next earnings: not announced yet

What 14 analyst firms say about ACLARIS THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

3.90 USD+0.29 (+8.03%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+168.1%to the avg target 10.45 USD+6.55 USD
Buy 10 · Hold 1 · Sell 0

11 rated views · 14 analyst/firm records · 14 firms

Latest report28 Oct 2026avg report date 15 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 7 reports on ACRS from 6 analyst firms in the last 90 days (14 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target, 2 lowered it and 2 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: Canaccord Genuity raised its target from $10.00 (set 1 Sep 2026) to $13.00 on 30 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Canaccord GenuityEdward NashBuy1 Sep 202610.00 USD
Cantor FitzgeraldPrakhar AgrawalBuy15 Jun 2026—
Craig-HallumAdam VogelConflictConflicting reports · excluded28 Oct 20269.00 USD
GuggenheimSeamus FernandezBuy5 May 202612.00 USD
H.C. WainwrightRaghuram SelvarajuBuy28 Oct 202616.00 USD
JefferiesRoger SongBuy6 Jan 20267.00 USD
Leerink PartnersThomas J SmithBuy6 Aug 20269.00 USD
Lifesci CapitalKatherine DellorussoBuy1 Jun 202613.00 USD
OppenheimerJeff JonesBuy16 Apr 202610.00 USD
Piper SandlerBiren AminBuy18 Oct 202611.00 USD
UBSUnnamed analyst—16 Apr 202610.00 USD
WedbushMartin FanBuy28 Oct 20268.00 USD
Weiss RatingsUnnamed analyst—21 Sep 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:14 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.